Home › Funds › Citigroup Inc › ENOV
Citigroup Inc position in ENOV
ENOVIS CORPORATION · Health Care
Latest position (Q2 2026)385.22K sh
Reported value held$7.97M
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 4.50K | $247.00K | New |
| Q3 2022 | 11.43K | $526.00K | Add |
| Q4 2022 | 10.33K | $553.08K | Reduce |
| Q1 2023 | 14.40K | $770.42K | Add |
| Q2 2023 | 13.61K | $872.87K | Reduce |
| Q3 2023 | 12.43K | $655.49K | Reduce |
| Q4 2023 | 14.15K | $792.63K | Add |
| Q1 2024 | 42.94K | $2.68M | Add |
| Q2 2024 | 31.69K | $1.43M | Reduce |
| Q3 2024 | 36.65K | $1.58M | Add |
| Q4 2024 | 83.04K | $3.64M | Add |
| Q1 2025 | 326.26K | $12.47M | Add |
| Q2 2025 | 256.16K | $8.03M | Reduce |
| Q3 2025 | 262.71K | $7.97M | Add |
| Q4 2025 | 253.29K | $6.75M | Reduce |
| Q1 2026 | 9.71K | $221.02K | Reduce |
| Q2 2026 | 385.22K | $7.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENOV
- BlackRock Inc 10.30M sh · $213.12M · Q2 2026
- Vanguard Group 6.44M sh · $171.52M · Q4 2025
- UBS Group AG 2.82M sh · $58.48M · Q2 2026
- Fidelity Management & Research (FMR) 2.21M sh · $45.72M · Q2 2026
- Goldman Sachs Group 1.77M sh · $36.69M · Q2 2026
- Geode Capital Management 1.50M sh · $30.98M · Q2 2026
- Morgan Stanley 1.07M sh · $22.14M · Q2 2026
- Charles Schwab Investment Management 998.63K sh · $20.67M · Q2 2026
- Millennium Management 803.32K sh · $16.63M · Q2 2026
- Northern Trust Corp 671.77K sh · $13.91M · Q2 2026
- Royce & Associates 662.18K sh · $13.71M · Q2 2026
- AQR Capital Management 590.65K sh · $12.23M · Q2 2026